Drozitumab, a Human Antibody to Death Receptor 5, Has Potent Antitumor Activity against Rhabdomyosarcoma with the Expression of Caspase-8 Predictive of ResponseZhigang Kang, Liang Cao|Clinical Cancer Research|2011Cited by 42